Iovance Biotherapeutics Inc (IOVA) Event Aug. 04, 2022, 00:00 UTC (47% Neutral) IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:03 p.m. 🏢 Iovance Biotherapeutics Inc (IOVA) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-191.00M $-156.80M $-34.20M -21.81% 📈 Total Assets $777.33M $610.88M $166.46M +27.25% 📈 Total Liabilities $155.67M $138.19M $17.49M +12.65% 📉 Stockholders' Equity $744.41M $-986.99M $1.73B +175.42% 📈 Operating Income/Loss $-157.00M $-191.45M $34.45M +18.00% 📉 R&D Expense N/A N/A N/A +0.00% ➡️ Earningspersharebasic $-1.04 $-1.21 $0.17 +14.05% 📈 Earningspersharediluted $-1.04 $-1.21 $0.17 +14.05% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Iovance Biotherapeutics Inc (IOVA) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document